“Quidel, a maker of COVID-19 tests, agreed to buy Ortho Clinical Diagnostics for about $6bn, less than a year since the The Carlyle Group-backed firm went public.” Ortho robi dokładnie 1:1 to samo co Cormay! To jest kolejna jaskółka, że ten rynek eksploduje. Pytanie tylko, kiedy.